Intrinsic Value

The intrinsic value of VentriPoint Diagnostics Ltd (VPTDF) under the Base Case is 0.002 USD per share. Compared with the current market price of 0.0453 USD, the stock appears Overvalued by 96% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

VPTDF Intrinsic Value
$0.002
Overvaluation 96%
Intrinsic Value
Price $0.0453
Alert me when VPTDF is below its intrinsic value
Today $0.0016 · 96.4% below the current price

VPTDF is cheaper than usual. Still overvalued, but less so than on 79% of days in the past 5 years.

Alternatives to VPTDF

Fundamental Analysis

What VentriPoint Diagnostics Does

Health Care

VentriPoint Diagnostics Ltd. makes software that helps doctors measure and analyze the heart, especially the right ventricle, using medical images such as MRI and CT scans. Its tools are built to turn raw scan data into clear measurements and reports that support diagnosis and follow-up care, particularly in cardiac medicine and congenital heart disease.

Headquarters
Canada CA
IPO date
Nov 9, 2005
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
VentriPoint Diagnostics Ltd

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Ownership

VPT Insider Trading
Buy and sell transactions by insiders

Continue VPTDF Research

Decided on VentriPoint Diagnostics? Get an email when VPTDF reaches the price you’d buy at. Free with an account.

Other VentriPoint Diagnostics listings

What is the Intrinsic Value of one VPTDF stock?

The intrinsic value for VentriPoint Diagnostics Ltd (VPTDF) under the Base Case is 0.002 USD.

Is VPTDF stock undervalued or overvalued?

Compared with the current market price of 0.0453 USD, the stock appears Overvalued by 96% .

How reliable are our estimates? See how past valuations played out
Back to Top